Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Noa
    Member
    • Jun 2011
    • 62

    #1

    Sequencing bacterial mRNA with Illumina stranded kits

    I am interested in directionally sequencing mRNA from bacteria (who do not have a polyA tail). Since Illumina's Ribo-zero kit depletes only mammalian rRNA I will not be able to use it. Therefore, I want to use my own bacterial Ribo-Zero kit and then use the Illumina stranded (directional) mRNA sequencing kit.

    The main difference I see between the Ribo-Zero total RNA stranded kit and the mRNA stranded kit (apart from the mRNA/total RNA isolation procedure) is in the buffers used for fragmentation (FPF buffer for mRNA, EFP buffer for total RNA). Can the FPF buffer of the directional mRNA seq kit be used for fragmentation in solution rather than on the beads?
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #2
    I don't know the answer to your specific question, but we frequently use ribo-zero with the TruSeq RNA prep kit by skipping the polyA step and adding 10-50ng of depleted RNA to the fragmentation step.

    Call Illumina Tech support. Unlike most companies they actually tend to be able to provide useful answers.

    --
    Phillip

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Yesterday, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    71 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...